Non-small cell lung cancer (NSCLC)
- Test actionable driver mutations + PD-L1 in advanced disease
- Localized disease → surgery/radiation ± systemic therapy
- Driver-positive tumors → matched targeted therapy
- No driver → immunotherapy ± platinum chemotherapy
- Adjuvant/neoadjuvant systemic therapy now common in selected stages
- Smoking cessation remains clinically important after diagnosis
Use at a glance
- Test actionable driver mutations + PD-L1 in advanced disease
Treatment options
- Localized disease → surgery/radiation ± systemic therapy
Other treatment options
- Driver-positive tumors → matched targeted therapy
- No driver → immunotherapy ± platinum chemotherapy
- Smoking cessation remains clinically important after diagnosis
Choosing treatment
- Adjuvant/neoadjuvant systemic therapy now common in selected stages
Self-check
- What is recommended for No driver in Non-small cell lung cancer (NSCLC)?
immunotherapy ± platinum chemotherapy.
- What is recommended for Localized disease in Non-small cell lung cancer (NSCLC)?
surgery/radiation ± systemic.
Drugs used for this (2)
All clinical uses · Open the interactive console ↗
